Ciprofloxacin; Ciprofloxacin Hydrochloride Patent Expiration
Ciprofloxacin; Ciprofloxacin Hydrochloride was first introduced by Bayer Healthcare Pharmaceuticals Inc
Ciprofloxacin; Ciprofloxacin Hydrochloride Patents
Given below is the list of patents protecting Ciprofloxacin; Ciprofloxacin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cipro Xr |
US7709022 (Pediatric) | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
Dec 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr |
US8187632 (Pediatric) | Sustained-release preparations of quinolone antibiotics |
Dec 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr | US7709022 | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
Jun 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr | US8187632 | Sustained-release preparations of quinolone antibiotics |
Jun 23, 2021
(Expired) | Bayer Hlthcare |
Ciprofloxacin; Ciprofloxacin Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List